NEW Partner: PELOBiotech is strenghtening its leading position in the field of MSCs & GMP.

16. July 2020
pelobiotech-gmbh-sfd-500ml.jpg

Cell culture is a critical component of research, development and production in the life sciences. Cell culture media in particular, has a significant impact on the efficacy and sensitivity control of the cell culture microenvironment. PELOBiotech is strenghtening its leading position in the field of MSCs & GMP: We added two media for MSCs to our portfolio called CellCor, a serum free chemically defined media composed of over 200 known compounds.

“MSCs are gaining more and more significance in research,” says Dr. Peter Frost, CEO PELOBiotech. “We are happy to open the European market to this promising brand and excited to have Xcell Therapeutics onboard with its extensive knowledge in the GMP sector.”

Through 10 years of tenacious research, producer Xcell Therapeutics , South Korea, developed CellCor™ SFD MSC and CellCor™ CD MSC products, which provide superior performance with the upmost focus safety and quality, assured by strict adherence to regulated standards following good manufacturing practices. CellCor™ does not contain any animal nor plant derived components, they are hPL free, and Exosome free, available in R&D and GMP quality.